In Vientiane, the capital of Laos nourished by the Mekong River, a modern pharmaceutical manufacturing base brims with vigorous vitality. As one of Laos’ officially registered chemical pharmaceutical enterprises, BigBear Pharma (Laos) embarked on preparation in 2020 and officially commenced production in 2021. Guided by its mission of “Star of Health, Caring for People”, it has turned a new page in safeguarding public health, witnessed by investors and Laos’ Minister of Health.
Rooted Locally, Filling the Gap in High-End Pharmaceutical Manufacturing
At the initial stage of factory construction, BigBear Pharma spent two years on rigorous site selection and inspection before settling in Vientiane. The enterprise invested heavily in industrial upgrading and built production workshops with world class advanced standards. This has not only eased Laos’ long standing shortage of medical supplies and medicines but also filled the local gap in high end pharmaceutical manufacturing. Over the past two years, BigBear Pharma has pursued continuous innovation and steady operation, with key economic indicators ranking among the top of its domestic counterparts, emerging as a vital force transforming regional healthcare ecosystems.
Quality as the Lifeblood, Fortifying Safety Barriers
BigBear Pharma always regards quality as its corporate lifeblood. From the early construction phase, the company has fully implemented the Total Quality Management (TQM) system aligned with international standards, strictly complied with GMP specifications throughout the production process, and obtained certification under Laos’ latest national GMP standards, taking the lead in the industry. To guarantee superior pharmaceutical quality, BigBear Pharma has introduced multiple sets of internationally advanced equipment, including fully automatic granule production and packaging lines, soft/hard capsule manufacturing and filling equipment, tablet presses, as well as cutting edge testing instruments such as high performance liquid chromatography systems. These ensure every tablet and dose is safe and effective, earning an outstanding reputation for quality in domestic and international markets.
Diversified Layout, a Trusted Guardian of Public Health
Upholding the principle of “People’s Health First, Quality Always Supreme”, BigBear Pharma has built a comprehensive product portfolio covering multiple therapeutic areas. Its flagship products span key fields including liver diseases, lung diseases, hematology, oncology and chronic illnesses. Boasting remarkable advantages in scale, technology and brand, BigBear Pharma’s products have won high recognition from Laos’ Ministry of Health and gained trust among patients.
Looking Ahead: Towards a World-Class Pharmaceutical Group
Going forward, BigBear Pharma will continue to be guided by the Scientific Outlook on Development and implement its development strategy of “overall integration, innovation driven progress, optimization and upgrading, refined and robust growth”. Through three to five years of persistent efforts, the enterprise strives to develop into a compact, high efficiency and sustainable world class modern pharmaceutical group with domestic and international prominence, featuring innovation leadership, intensive efficiency, open win win cooperation and harmonious prosperity, contributing more to the pharmaceutical and healthcare industries of Laos and the globe.
